DHCR7-DT and hydrops fetalis: The AP convertase inhibitor FH was not elevated in HF patients, however, low levels (i.e., ≤249 μg/mL) were associated with impaired transplant-free survival during follow-up, even in the adjusted analyses, further suggesting a link between AP activation and HF severity.